safety and efficacy of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma
Published 3 years ago • 1.5K plays • Length 5:12Download video MP4
Download video MP3
Similar videos
-
4:46
atezo plus bev demonstrates efficacy in preventing recurrence in patients with high-risk hcc
-
0:49
dr. kaseb on safety profile of atezolizumab plus bevacizumab in hcc
-
3:55
the use of immunotherapy in hcc – efficacy and safety
-
3:58
atezolizumab and bevacizumab for upfront unresectable hcc
-
3:53
improvement in rfs for atezolizumab plus bevacizumab vs active surveillance without compromising qol
-
2:40
key outcomes of the phase 1b of atezolizumab and bevacizumab for advanced hcc
-
3:12
tislelizumab os benefit vs sorafenib as first line treatment for unresectable hepatocellular car...
-
3:05
imbrave150: updated data on atezo plus bev versus sorafenib in hcc
-
0:37
combination atezolizumab plus bevacizumab improved quality of life in hcc
-
1:04
dr. lee on trial data evaluating the atezolizumab/bevacizumab in unresectable hcc
-
3:42
imbrave050: adjuvant atezolizumab with bevacizumab in high-risk hcc
-
1:09
ahmed kaseb, md, considers the effectiveness of bevacizumab atezolizumab in hcc
-
1:03
phase iii emerald-1: bevacizumab and durvalumab with tace improves pfs in unresectable hcc
-
1:28
dr. jordi bruix on efficacy and safety of regorafenib in hcc after sorafenib
-
7:05
the efficacy and safety of double immunity combined stride regimen in unresectable hcc
-
0:29
similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab a... | rtcl.tv
-
4:21
the use of immunotherapy in hcc – in depth subgroup analyses and challenges
-
3:05
richard s. finn, md, tells us about the safety profile of atezolizumab & bevacizumab from imbrave150
-
23:25
dr bharat | role of tecentriq atezolizumab avastin bevacizumab as 1l in unresectable hcc